These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22164771)

  • 1. Vitexin inhibits polyubiquitin synthesis by the ubiquitin-conjugating enzyme E2-25K.
    Helms KM; Wilson RC; Ogungbe IV; Setzer WN; Twigg PD
    Nat Prod Commun; 2011 Oct; 6(10):1411-6. PubMed ID: 22164771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core domain mutation (S86Y) selectively inactivates polyubiquitin chain synthesis catalyzed by E2-25K.
    Mastrandrea LD; Kasperek EM; Niles EG; Pickart CM
    Biochemistry; 1998 Jul; 37(27):9784-92. PubMed ID: 9657692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and function of ubiquitin conjugating enzyme E2-25K: the tail is a core-dependent activity element.
    Haldeman MT; Xia G; Kasperek EM; Pickart CM
    Biochemistry; 1997 Aug; 36(34):10526-37. PubMed ID: 9265633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The E2-25K ubiquitin-associated (UBA) domain aids in polyubiquitin chain synthesis and linkage specificity.
    Wilson RC; Edmondson SP; Flatt JW; Helms K; Twigg PD
    Biochem Biophys Res Commun; 2011 Feb; 405(4):662-6. PubMed ID: 21281599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodination of tyrosine 59 of ubiquitin selectively blocks ubiquitin's acceptor activity in diubiquitin synthesis catalyzed by E2(25K).
    Pickart CM; Haldeman MT; Kasperek EM; Chen Z
    J Biol Chem; 1992 Jul; 267(20):14418-23. PubMed ID: 1321147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclization of polyubiquitin by the E2-25K ubiquitin conjugating enzyme.
    Yao T; Cohen RE
    J Biol Chem; 2000 Nov; 275(47):36862-8. PubMed ID: 10906148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of E2-25K/UBB+1 interaction leading to proteasome inhibition and neurotoxicity.
    Ko S; Kang GB; Song SM; Lee JG; Shin DY; Yun JH; Sheng Y; Cheong C; Jeon YH; Jung YK; Arrowsmith CH; Avvakumov GV; Dhe-Paganon S; Yoo YJ; Eom SH; Lee W
    J Biol Chem; 2010 Nov; 285(46):36070-80. PubMed ID: 20826778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of full-length ubiquitin-conjugating enzyme E2-25K (huntingtin-interacting protein 2).
    Wilson RC; Hughes RC; Flatt JW; Meehan EJ; Ng JD; Twigg PD
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 May; 65(Pt 5):440-4. PubMed ID: 19407372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N-terminal extension of UBE2E ubiquitin-conjugating enzymes limits chain assembly.
    Schumacher FR; Wilson G; Day CL
    J Mol Biol; 2013 Nov; 425(22):4099-111. PubMed ID: 23871895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of a diubiquitin conjugate and a model for interaction with ubiquitin conjugating enzyme (E2).
    Cook WJ; Jeffrey LC; Carson M; Chen Z; Pickart CM
    J Biol Chem; 1992 Aug; 267(23):16467-71. PubMed ID: 1322903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2-25K mediates US11-triggered retro-translocation of MHC class I heavy chains in a permeabilized cell system.
    Flierman D; Coleman CS; Pickart CM; Rapoport TA; Chau V
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11589-94. PubMed ID: 16868077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SUMO modification of the ubiquitin-conjugating enzyme E2-25K.
    Pichler A; Knipscheer P; Oberhofer E; van Dijk WJ; Körner R; Olsen JV; Jentsch S; Melchior F; Sixma TK
    Nat Struct Mol Biol; 2005 Mar; 12(3):264-9. PubMed ID: 15723079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning of human polyubiquitin cDNAs and a ubiquitin-binding assay involving its in vitro translation product.
    Kim NS; Yamaguchi T; Sekine S; Saeki M; Iwamuro S; Kato S
    J Biochem; 1998 Jul; 124(1):35-9. PubMed ID: 9644242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenolic compounds from Byrsonima crassifolia L. bark: phytochemical investigation and quantitative analysis by LC-ESI MS/MS.
    Maldini M; Montoro P; Pizza C
    J Pharm Biomed Anal; 2011 Aug; 56(1):1-6. PubMed ID: 21571480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory activity of the hexane extract of Byrsonima crassifolia seeds in experimental animal models.
    Muniz Ramirez A; Flores Cotera LB; Perez Gutierrez RM
    Altern Ther Health Med; 2013; 19(1):26-36. PubMed ID: 23341424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E1 on the move.
    VanDemark AP; Hill CP
    Mol Cell; 2005 Feb; 17(4):474-5. PubMed ID: 15721250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin-conjugating enzyme E2-25K increases aggregate formation and cell death in polyglutamine diseases.
    de Pril R; Fischer DF; Roos RA; van Leeuwen FW
    Mol Cell Neurosci; 2007 Jan; 34(1):10-9. PubMed ID: 17092742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the binding interface between ubiquitin and class I human ubiquitin-conjugating enzyme 2b by multidimensional heteronuclear NMR spectroscopy in solution.
    Miura T; Klaus W; Gsell B; Miyamoto C; Senn H
    J Mol Biol; 1999 Jul; 290(1):213-28. PubMed ID: 10388568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of ubiquitin conjugating enzyme E2-230K: catalysis involving a thiol relay?
    Berleth ES; Pickart CM
    Biochemistry; 1996 Feb; 35(5):1664-71. PubMed ID: 8634298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.